← Evidence map

ArticleFrontiers in oncology2022

Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies.

Carmen Miano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35664762